NCT03739801 2020-03-27
MM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
University of Southern California
Phase 1/2 Withdrawn
Clinical Trials
1 trialsPhase 1/2 × Locally Advanced Unresectable Gastric Adenocarcinoma × irinotecan sucrosofate × Clear all